Product Detail

Name: Bivalirudin  

Feature: 

In patients with elective PCI, the incidence of bleeding can be significantly reduced, and the risk of total clinical outcome decreased by 14%. It does not cause antibody-mediated thrombocytopenia.

It is reversibly combined with thrombin, with short half-life, and is not prone to ischemic and hemorrhagic complications.

It is mainly excreted through the kidney and can be safely used in patients with renal damage.

Composition:

Assay: 99%

Appearance: White powder

CAS No. 128270-60-0

Packing: 25kg

Shelf Life: 2 years

Storage: Store in cool and dry area

Certification:ISO.